Jia Cheng1, Zhe Xiong1, Lara J Duffney1, Jing Wei1, Aiyi Liu2, Sihang Liu1, Guo-Jun Chen3, Zhen Yan4. 1. Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York. 2. Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 3. Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 4. Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; Department of Physiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. Electronic address: zhenyan@buffalo.edu.
Abstract
BACKGROUND: Methylphenidate (MPH), a psychostimulant drug used to treat attention-deficit/hyperactivity disorder, produces the effects of increasing alertness and improving attention. However, misuse of MPH has been associated with an increased risk of aggression and psychosis. We sought to determine the molecular mechanism underlying the complex actions of MPH. METHODS: Adolescent (4-week-old) rats were given one injection of MPH at different doses. The impact of MPH on glutamatergic signaling in pyramidal neurons of prefrontal cortex was measured. Behavioral changes induced by MPH were also examined in parallel. RESULTS: Administration of low-dose (.5 mg/kg) MPH selectively potentiated N-methyl-D-aspartate receptor (NMDAR)-mediated excitatory postsynaptic currents (EPSCs) via adrenergic receptor activation, whereas high-dose (10 mg/kg) MPH suppressed both NMDAR-mediated and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor-mediated EPSCs. The dual effects of MPH on EPSCs were associated with bidirectional changes in the surface level of glutamate receptor subunits. Behavioral tests also indicated that low-dose MPH facilitated prefrontal cortex-mediated temporal order recognition memory and attention. Animals injected with high-dose MPH exhibited significantly elevated locomotive activity. Inhibiting the function of synaptosomal-associated protein 25, a key SNARE protein involved in NMDAR exocytosis, blocked the increase of NMDAR-mediated EPSCs by low-dose MPH. In animals exposed to repeated stress, administration of low-dose MPH effectively restored NMDAR function and temporal order recognition memory via a mechanism dependent on synaptosomal-associated protein 25. CONCLUSIONS: These results provide a potential mechanism underlying the cognitive-enhancing effects of low-dose MPH as well as the psychosis-inducing effects of high-dose MPH.
BACKGROUND:Methylphenidate (MPH), a psychostimulant drug used to treat attention-deficit/hyperactivity disorder, produces the effects of increasing alertness and improving attention. However, misuse of MPH has been associated with an increased risk of aggression and psychosis. We sought to determine the molecular mechanism underlying the complex actions of MPH. METHODS: Adolescent (4-week-old) rats were given one injection of MPH at different doses. The impact of MPH on glutamatergic signaling in pyramidal neurons of prefrontal cortex was measured. Behavioral changes induced by MPH were also examined in parallel. RESULTS: Administration of low-dose (.5 mg/kg) MPH selectively potentiated N-methyl-D-aspartate receptor (NMDAR)-mediated excitatory postsynaptic currents (EPSCs) via adrenergic receptor activation, whereas high-dose (10 mg/kg) MPH suppressed both NMDAR-mediated and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor-mediated EPSCs. The dual effects of MPH on EPSCs were associated with bidirectional changes in the surface level of glutamate receptor subunits. Behavioral tests also indicated that low-dose MPH facilitated prefrontal cortex-mediated temporal order recognition memory and attention. Animals injected with high-dose MPH exhibited significantly elevated locomotive activity. Inhibiting the function of synaptosomal-associated protein 25, a key SNARE protein involved in NMDAR exocytosis, blocked the increase of NMDAR-mediated EPSCs by low-dose MPH. In animals exposed to repeated stress, administration of low-dose MPH effectively restored NMDAR function and temporal order recognition memory via a mechanism dependent on synaptosomal-associated protein 25. CONCLUSIONS: These results provide a potential mechanism underlying the cognitive-enhancing effects of low-dose MPH as well as the psychosis-inducing effects of high-dose MPH.
Authors: Eunice Y Yuen; Wenhua Liu; Ilia N Karatsoreos; Jian Feng; Bruce S McEwen; Zhen Yan Journal: Proc Natl Acad Sci U S A Date: 2009-07-29 Impact factor: 11.205
Authors: Conor Liston; Melinda M Miller; Deena S Goldwater; Jason J Radley; Anne B Rocher; Patrick R Hof; John H Morrison; Bruce S McEwen Journal: J Neurosci Date: 2006-07-26 Impact factor: 6.167
Authors: P Shaw; K Eckstrand; W Sharp; J Blumenthal; J P Lerch; D Greenstein; L Clasen; A Evans; J Giedd; J L Rapoport Journal: Proc Natl Acad Sci U S A Date: 2007-11-16 Impact factor: 11.205
Authors: Alberto Fernández; Javier Quintero; Roberto Hornero; Pilar Zuluaga; Marta Navas; Carlos Gómez; Javier Escudero; Natalia García-Campos; Joseph Biederman; Tomás Ortiz Journal: Biol Psychiatry Date: 2008-12-21 Impact factor: 13.382
Authors: Matthew D Wiley; Laura B Poveromo; John Antapasis; Carolina M Herrera; Carlos A Bolaños Guzmán Journal: Neuropsychopharmacology Date: 2008-10-15 Impact factor: 7.853
Authors: Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Daniella M Coelho; Ben Hur Mussulini; Mery S L Pereira; Mariana M Parisi; Florencia Barbé-Tuana; Diogo L de Oliveira; Carmen R Vargas; Angela T S Wyse Journal: Mol Neurobiol Date: 2015-05-24 Impact factor: 5.590
Authors: Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Matheus Grunevald; Letícia F Pettenuzzo; Giselli Scaini; Emilio L Streck; Carlos A Netto; Angela T S Wyse Journal: Mol Neurobiol Date: 2016-06-21 Impact factor: 5.590